Gynecologic Oncology | Specialty

The OncLive Gynecologic Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of gynecologic cancers, including ovarian cancer, endometrial cancer, and uterine cancer, among others. This section features news articles, interviews with gynecologic oncologists in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in gynecologic cancers.

Study Confirms Extending Testing to Every 3 Years in Women Who Test Negative for the HPV Virus

May 18th 2011

A large-scale study of HPV testing and Pap smear for cervical cancer screening confirms that women can safely extend screening intervals from 1 to 3 years.

Dr. Markman on HPV Testing to Detect Cervical Cancer

May 18th 2011

Dr. Markman on HPV Testing to Detect Cervical Cancer

Dr. Pecora on HPV Cervical Cancer Findings

May 18th 2011

Dr. Pecora on HPV Cervical Cancer Findings

Dr. Markman Discusses the Olaparib Phase II Trial

May 18th 2011

Dr. Markman Discusses the Olaparib Phase II Trial

Dr. Markman Discusses the Importance of Screening

May 18th 2011

Dr. Markman Discusses the Importance of Cancer Screening

Facilitating Intraperitoneal Chemotherapy Completion

May 10th 2011

Fiona McCaughan on Nurses Facilitating Intraperitoneal Chemotherapy Completion

Smoking Increases Breast Cancer Risk in Postmenopausal Women

May 10th 2011

Investigators have reported an increased risk of invasive breast cancer in postmenopausal women who are or were cigarette smokers

Intraperitoneal Struggles in Ovarian Cancer Treatments

May 9th 2011

Oncology Nurse Fiona McCaughan on Struggles Facing Intraperitoneal Ovarian Cancer Treatments

Age Cutoff for Pap Tests Questioned

May 2nd 2011

More than 12% of newly diagnosed cervical cancers occurred in women aged 70 to 85 years during 2000 to 2006

Dr. Karlan Describes AMG 386 Side Effects

April 29th 2011

Dr. Karlan Describes AMG 386 Side Effects Found in the Phase II Ovarian Cancer Trial

Tinkering With Regimen Leads to Better Outcomes in Vulvar Cancer

April 29th 2011

Investigators in a cooperative group trial reported that modifications in a chemoradiation regimen for locally advanced vulvar cancer boosted both clinical and pathologic complete response rates

MicroRNA May Predict Response to Bevacizumab

April 28th 2011

The results of a small clinical trial showed that low-level expression of a microRNA correlated with improved progression-free survival

Study Indicates Cetuximab Provides No Benefit in Advanced Cervical Cancer

April 28th 2011

Results of a phase II cooperative-group trial showed that the targeted agent cetuximab demonstrated minimal activity in patients with advanced, platinum-resistant cervical cancer

Dr. Carey Discusses the Need for Targeted Therapy in TNBC

April 26th 2011

Dr. Lisa Carey Discusses the Need for Targeted Therapy in Triple Negative Breast Cancer (TNBC)

FDA Grants NKTR-102 Orphan Drug Status for Treatment of Ovarian Cancer

April 26th 2011

Nektar Therapeutics announced that its oncology drug candidate, NKTR-102, has been granted orphan drug status

Phase II AMG 386 and Paclitaxel Combination Trial

April 26th 2011

Analysis of the Phase II AMG 386 and Paclitaxel Combination Trial

Study Finds that Air Pollution Can Lead to Breast Cancer

April 21st 2011

Exposure to air pollution at certain times in a woman's life can leave her more susceptible to premenopausal breast cancer

FDA Approves New Test for HPV

April 20th 2011

Cervical cancer affects about 470,000 women each year and now the disease has a new tool to combat its spread

New Study Findings Change the Standard of Care for Women With Breast Cancer

April 19th 2011

Contrary to the traditionally slow pace of research adoption, the American College of Surgeons Oncology Group's Z0011 trial has seemingly changed practice overnight

The Meaning of Breast Cancer Risk and Surveillance Behaviors Among High-Risk African-American Women

April 15th 2011

A breast cancer diagnosis is a highly distressing, life-changing experience